| Measuring competitive exclusion in non–small cell lung cancer N Farrokhian, J Maltas, M Dinh, A Durmaz, P Ellsworth, M Hitomi, ... Science Advances 8 (26), eabm7212, 2022 | 35 | 2022 |
| Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma JA Scarborough, E McClure, P Anderson, A Dhawan, A Durmaz, ... Iscience 23 (7), 2020 | 29* | 2020 |
| Adaptations of an RNA virus to increasing thermal stress S Singhal, CM Leon Guerrero, SG Whang, EM McClure, HG Busch, B Kerr PLoS One 12 (12), e0189602, 2017 | 15 | 2017 |
| The MAP kinase signal transduction pathway: promising therapeutic targets used in the treatment of melanoma E McClure, MJ Carr, JS Zager Expert Review of Anticancer Therapy 20 (8), 687-701, 2020 | 10 | 2020 |
| Science Forum: A low-cost, open-source evolutionary bioreactor and its educational use V Gopalakrishnan, D Crozier, KJ Card, LD Chick, NP Krishnan, E McClure, ... Elife 11, e83067, 2022 | 8* | 2022 |
| Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery EM McClure, G Sedor, Y Jin, MW Kattan Clinical and Translational Radiation Oncology 43, 100678, 2023 | 4 | 2023 |
| Atypical fibroxanthoma: outcomes from a large single institution series E McClure, MJ Carr, A Patel, SM Hussnain Naqvi, Y Kim, M Harrington, ... Cancer Control 30, 10732748231155699, 2023 | 4 | 2023 |
| The evolving treatment landscape of Merkel cell carcinoma N Singh, EM McClure, T Akaike, SY Park, ET Huynh, PH Goff, P Nghiem Current Treatment Options in Oncology 24 (9), 1231-1258, 2023 | 3 | 2023 |
| The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update E McClure, A Patel, MJ Carr, J Sun, JS Zager Expert Review of Precision Medicine and Drug Development 6 (1), 19-29, 2021 | 3 | 2021 |
| Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec EM McClure, N Singh, KG Abson, S Bhatia, HJ Gray, LS Brown, ... JAAD Case Reports 32, 15-17, 2023 | 1 | 2023 |
| Image guidance improves freedom from recurrence in superficial radiation therapy for non-melanoma skin cancer E McClure, G Sedor, M Moloney, Y Jin, MW Kattan, L Yu medRxiv, 2022.09. 29.22280478, 2022 | 1 | 2022 |
| Developments in therapy for brain metastases in melanoma patients JG Wilkes, A Patel, E McClure, Y Pina, JS Zager Expert Opinion on Pharmacotherapy 22 (11), 1443-1453, 2021 | 1 | 2021 |
| A case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy H Ghali, EM McClure, EL Foster JAAD Case Reports 47, 10-13, 2024 | | 2024 |
| Image guidance improves freedom from recurrence rate after superficial radiation therapy for non-melanoma skin cancer E McClure, G Sedor, M Moloney, Y Jin, L Yu, MW Kattan Advances in Radiation Oncology, 2024 | | 2024 |
| Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec N Singh, E McClure, C Doolittle-Amieva, U Parvathaneni, S Bhatia, ... JAAD Case Reports 36, 15-17, 2023 | | 2023 |
| 434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option E McClure, T Akaike, ET Huynh, N Harikrishnan, K Lachance, C Church, ... Journal of Investigative Dermatology 143 (5), S75, 2023 | | 2023 |
| Nutritional Diseases C Kesty, M Hooper, E McClure, E Chea, C Bartus Roxburgh's Common Skin Diseases, 385-398, 2022 | | 2022 |
| Omission of Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma MJ Carr, E McClure, A Patel, J Sun, R Panchaud, SM Naqvi, Y Kim, K Tsai, ... ANNALS OF SURGICAL ONCOLOGY 28 (SUPPL 1), S125-S126, 2021 | | 2021 |
| 609. Differing Genotypic Contexts Between E. coli and A. baumannii Modulate the Role of blaADC-7 in the Development of Antibiotic Collateral Sensitivity E McClure, J Newman, N Krishnan, J Rutter, AM Hujer, MD Adams, ... Open Forum Infectious Diseases 6 (Suppl 2), S284, 2019 | | 2019 |
